Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Uses of modified ELR-CXC chemokine G31P to treat cancer

Uses of modified ELR-CXC chemokine G31P to treat cancer

US Patent 8299019 · Granted Oct 30, 2012

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Zika virus immunogenic compositions2024
Pharmaceutical combination comprising an ALK inhibitor and a SHP2 inhibitor2024
Preparation method of doped ZnO catalyst and synthesis method of higher alcohol 2024
Immunogenic composition for MERS coronavirus infection2021
Pharmaceutical combinations2019
Esters or salts of 2-hydroxy-4-propylcyclohepta-2,4,6-trienone and application t2018
Position and orientation determination system and method2017
Diaminoguanidine derivatives and application thereof in preparation of animal gr2017
Inhibition of HIF-1 activation for anti-tumor and anti-inflammatory responses2015
Conjugate for photodynamic diagnosis or therapy and method for preparing same2015
Nitropyridinyl ethyleneimine compound, the pharmaceutical composition containing2015
Nitropyridinyl ethyleneimine compound, the pharmaceutical composition containing2013